INSULIN GLARGINE VERSUS METFORMIN FOR THE FIRST-LINE TREATMENT OF EARLY TYPE 2 DIABETES
- Application ID: EP12799541
- Status: █ APPLICATION WITHDRAWN
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Sanofi-Aventis Deutschland GmbH is specialized in A61. Sanofi-Aventis Deutschland GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.